Abstract
Trans fatty acids (TFA) have been considered as an independent risk factor of coronary heart disease, sudden death and insulin-resistance, and different TFA isomers may have different effects on the progression of cardiovascular diseases such as atherosclerosis. The aim of the study was to investigate the effects of two major TFA, elaidic acid and linolelaidic acid which have the same number of carbons but a different number and configuration of trans bonds, on the proliferation of human umbilical vein smooth muscle cells (HUVSMC). Methyl thiazolyl tetrazolium and flow cytometry assays showed that the cell proliferation rose to 115.37 ± 0.39 and 117.5 ± 0.57 % and the cell number in the S phase of the cell cycle reached 27.7 ± 0.7 and 25.8 ± 2.8 % when treated with 50 μM elaidic acid and 20 μM linolelaidic acid, respectively. Quantitative real-time reverse transcriptase-polymerase chain reaction and Western blotting analyses showed that the two TFA increased the mRNA and protein expression levels of PCNA, CDK2 and Cyclin E in HUVSMC. Moreover, gas chromatography analysis showed that the total PUFA level of HUVSMC was lower after treatment with the two TFA, especially n-3 PUFA. These results suggested that linolelaidic acid exhibited a stronger proliferative effect on HUVSMC than elaidic acid, and regulation of CDK2 and Cyclin E may be important for the effect of the TFA on atherosclerosis.
Similar content being viewed by others
Abbreviations
- CHD:
-
Coronary heart disease
- DMEM:
-
Dulbecco’s modified eagle medium
- FBS:
-
Fetal bovine serum
- GC:
-
Gas chromatography
- HUVSMC:
-
Human umbilical vein smooth muscle cells
- LA:
-
Linoleic acid
- OA:
-
Oleic acid
- PUFA:
-
Polyunsaturated fatty acid(s)
- SCD:
-
Sudden cardiac death
- TFA:
-
Trans fatty acids
- VSMC:
-
Vascular smooth muscle cells
References
Food and Drug Administration (2003) Food labeling trans fatty acids in nutrition labeling nutrient content claims and health claims. J Federal Register 68:41434–41506
Kromhout D, Menotti A, Bloemberg B (1995) Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the seven countries study. Prev Med 24:308–315
Lopez-Garcia E, Schulze MB, Meigs JB (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135:562–566
Sundram K, French MA, Clandinin MT (2003) Exchanging partially hydrogenated fat for palmitic acid in the diet increases LDL-cholesterol and endogenous cholesterol synthesis in normocholesterolemic women. Eur J Nutr 42:188–194
Willett WC, Stampfer MJ, Manson JE (1993) Intake of trans-fatty acids and risk of coronary heart disease among women. Lancet 341:581–585
Willett WC (2006) Trans-fatty acids and cardiovascular disease-epidemiological data. Atheroscler Suppl 7:5–8
Erickson MD (2006) Deep frying: chemistry, nutrition, and practical applications, 2nd edn. American Oil Chemists Society, Urbana, p 447
Lemaitre RN, King IB, Mozaffarian D (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 114:209–215
Wang L, Hao Q, Wang YD et al (2011) Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells. Atherosclerosis 214:47–57
Davda RK, Stepniakowski KT, Lu G et al (1995) Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26:764–770
Yun MR, Lee JY, Park HS et al (2006) Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway. Pharmacol Res 54:97–102
Qiu B, Rao H, Hu JN et al (2012) The caspase pathway of linoelaidic acid (9t,12t–C18:2)-induced apoptosis in human umbilical vein endothelial cells. Lipids. doi:10.1007/s11745-012-3728-4
Cruz-Hernandez C, Deng Z, Zhou J (2004) Methods for analysis of conjugated linoleic acids and trans-18:1 isomers in dairy fats by using a combination of gas chromatography, silver-ion thin-layer chromatography/gas chromatography, and silver-ion liquid chromatography. J AOAC Int 87:545–562
Allison DB, Egan SK, Barraj LM (1999) Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 99:166–174
Lemaitre RN, King IB, Mozaffarian D (2006) Trans-fatty acids and sudden cardiac death. Atherosclerosis 7:13–15
Ferri N, Granata A, Pirola C (2008) Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/Cyclin E expression. Mol Pharmacol 74:144–153
Adon AM, Zeng XB, Harrison MK et al (2010) Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells. Mol Cell Biol 30:694–710
Jirawatnotai S, Aziyu A, Osmundson EC (2004) Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem 279:51100–51106
Martin A, Odajima J, Hunt SL (2005) Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell 7:591–598
Laufs U, Marra D, Node K (1999) 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem 274:21926–21931
Fouty BW, Rodman DM (2003) Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway. Circ Res 92:501–509
Rao S, Porter DC, Chen X (1999) Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci USA 96:7797–7802
Dyerberg J, Christensen JH, Astrup A et al (2006) Trans, and n-3 polyunsaturated fatty acids and vascular function—a yin yang situation? Atheroscler Suppl 7:33–35
Siddiqui RA, Harvey KA, Ruzmetov N et al (2009) N-3 fatty acids prevent whereas trans fatty acids induce vascular inflammation and sudden cardiac death. Brit J Nutri 102:1811–1819
Chrdigny JM, Destaillats F, Malpuech-Brugère C (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans fatty acids collaboration (TRANSFACT) study1–4. Am J Clin Nutr 87:558–566
Acknowledgments
This study was supported by the National Natural Science Foundation of China (30972482, 31060214), the Academic Leader Program of Jiangxi Province (2008DD00900), the Doctoral Fund of Ministry of Education of China (No. 20070403002), the Natural Science Foundation of Jiangxi Province (2008GQY0023), A Ph.D. subject fund from Education Department (20113601120004), the Natural Science Fund from Science and Technology Department of Jiangxi Province (20114BAB214016).
Conflict of interest
The authors have declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Li, XP., Luo, T., Li, J. et al. Linolelaidic Acid Induces a Stronger Proliferative Effect on Human Umbilical Vein Smooth Muscle Cells Compared to Elaidic Acid. Lipids 48, 395–403 (2013). https://doi.org/10.1007/s11745-012-3754-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-012-3754-2